XBIO

Xenetic Biosciences (XBIO)

About Xenetic Biosciences (XBIO)

Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.

Details

Daily high

$3.67

Daily low

$3.48

Price at open

$3.50

52 Week High

$5.20

52 Week Low

$2.78

Market cap

5.7M

Dividend yield

0.00%

Volume

866

Avg. volume

4,675

P/E ratio

-1.39

Xenetic Biosciences News